Why our steriles early development solutions help reach the patient quicker.
The rapid 10 percent growth of sterile drug product over the past 5 years is being aided by the rise in biologics, orphan drugs, oncology, therapeutics, as well as other environmental factors. As a result, Thermo Fisher Scientific understands the critical need for robust and flexible early development solutions, so you can:
- Overcome complex formulation challenges: solubility, stability, process
- Build a robust process development program
- Navigate a complex regulatory environment (IND, filing, etc.)
- Build success in early development to enable commercial success
- Shorten timelines to get to market quicker
Why Thermo Fisher Scientific’s Steriles Commercial Manufacturing solutions optimizes your chances of approval?
Scaling to commercial manufacturing can be arduous as you try to balance speed, regulatory and the supply chain. Thermo Fisher Scientific offers experience, reliability, and a broad range of sterile fill/finish commercial solutions that enable you to:
- Navigate a complex regulatory environment at a global scale
- Execute with speed and efficiency to get to market quicker
- Speed & execution of tech transfers
- Ensuring a robust supply chain within a global network
